Accelovance to add 70 clinical research jobs at Welsh site

By Zachary Brennan contact

- Last updated on GMT

Related tags: Wales

Accelovance to add 70 clinical research jobs at Welsh site
CRO (contract research organization) Accelovance has accepted a grant from the government of Wales and will open a new site in Swansea with 70 new employees.

With a focus on oncology, vaccines, and pain, CNS and osteoarthritis trials, Maryland-based Accelovance will look to use the site to expand on its recent acquisition of Altair Clinical​, which brought the company into the UK.  Altair adds new expertise in rare diseases and medical devices.

"This opportunity provided by the Welsh Government will allow us to shift our primary UK operations to Wales which provides a highly-talented scientific workforce to support the continued growth of Accelovance​," said Jamie Oliver, Executive Director for European and Asian Operations.

Michael Keens, VP of business development at Accelovance, told Outsourcing-Pharma.com that the bulk of the new employees will be from Swansea and will include clinical trial monitors, project managers and multilingual employees to work the call centers.

We know based on the employee skills in the area that the data call center will be filled quickly​,” Keens said.

The move to Wales will complement the company’s existing offices in Russia and Israel. Back in 2013, Accelovance also acquired the contract research division of Radiant Research​.

As far as the future for the company’s M&A, Keens said several staff members are exploring additional opportunities now in Europe.

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars